NCT02335047

Brief Summary

Passive flexion of the trunk (relative to the legs) may be accompanied by contraction of the psoas muscles, even when the subject has been told not to contract any muscles. The psoas contraction is involuntary and cannot be controlled by the subject. This lack of passivity might be concomitant with lower back pain: the impairment may be present when lower back pain is present and/or absent when lower back pain is absent. The study's primary objective is thus to determine the sensitivity and/or specificity of a clinical test for impaired hip flexor passivity in cases of lower back pain during passive flexion of the trunk (from the supine position,). The secondary objective is to show that a negative test (after administration of correcting measures) is correlated with a decrease in pain (i.e. pain intensity and the functional repercussions of pain).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jan 2015

Shorter than P25 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2014

Completed
17 days until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 9, 2015

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

October 2, 2015

Status Verified

October 1, 2015

Enrollment Period

1 month

First QC Date

December 15, 2014

Last Update Submit

October 1, 2015

Conditions

Keywords

reliabilityclinical testphysical therapy

Outcome Measures

Primary Outcomes (1)

  • Qualitative evaluation of impaired psoas muscle passivity during passive flexion of the trunk at the hips (while sitting).

    Visit 1 (Day 0)

Secondary Outcomes (1)

  • - A visual analog scale for pain

    - Visit 0 (Day 0: inclusion visit)

Study Arms (1)

lower back pain

OTHER
Other: Impaired passivity test

Interventions

Description of the test: the subject lies in the supine position on an exercise mat with his/her feet together. The subject is told to let his/her arms rest loosely by his/her side (as if they were ropes) and to keep the head aligned with the back. The examiner pulls the subject into the sitting position by pulling on the subject's wrists, with passive flexion of the trunk until the hip joint is fully flexed..

lower back pain

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18 and 30
  • Social security coverage
  • Ability to understand the study's objectives, procedures and risks and to provide informed, written consent
  • Having been informed about the results of the prior clinical examination.

You may not qualify if:

  • Past or concomitant infectious or cancerous diseases of the spine
  • Vertebral osteosynthesis
  • Acute neck or arm pain (recurrent dislocations of the glenohumeral joint, trauma in the previous 12 months, etc.)
  • Lower back pain with irradiation of pain below the buttocks
  • Known specific lower back pain or pain for which a differential diagnosis suggests an inflammatory, traumatic, cancerous or infectious cause
  • Subjects under legal guardianship
  • Known pregnancy
  • Simultaneous participation in another biomedical research study of a drug or medical device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mutter Catherine, MD

    Les Hôpitaux universitaires de Strasbourg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2014

First Posted

January 9, 2015

Study Start

January 1, 2015

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

October 2, 2015

Record last verified: 2015-10